当前位置： SCI文献检索 > World Journal of Gastrointestinal Oncology期刊下所有文献 > Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.

Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.

Abstract：

BACKGROUND:Bile duct cancer constitutes gallbladder cancer (GBC), intrahepatic cholangiocarcinoma (ICA), and extrahepatic cholangiocarcinoma (ECA). These three entities show morphological and immunohistochemical resemblance so that it is difficult to differentiate between primary ICA and liver metastasis of GBC, which sometimes becomes a point of discussion in clinical practice. Although these cancers demonstrate significant differences in their mutational landscape, several reports demonstrated shared genomic alteration in paired primary and metastatic site aids in distinguishing metastatic recurrence from second primary cancers. CASE SUMMARY:We present a 73-year-old female patient who underwent curative resection for GBC harboring epidermal growth factor receptor 2 (ERBB2) activating mutation on next-generation sequencing (NGS)-based genomic testing. One year later, a hepatic lesion was observed on follow-up imaging and she underwent surgical resection for a pathological diagnosis. The histological findings of the hepatic lesion were similar to those of the primary lesion. Additionally, using NGS panel testing, the hepatic lesion was found to have ERBB2 activating mutation, which is the identical mutation detected in the sequencing result of the primary site. ERBB2 activating mutation occurs more frequently in GBC than ICA and ECA. Therefore, in the present case, we think this molecular finding potentiated the diagnosis of the liver mass toward a metastatic recurrence. Additionally, this patient underwent HER2-targeted treatment with lapatinib in combination with capecitabin and obtained clinical benefit. CONCLUSION:This case illustrated NGS panel usefulness in distinguishing GBC recurrence from second primary cancer and HER2-targeted agent efficacy on ERBB2 mutated GBC.

journal_name

World J Gastrointest Oncol

journal_title

World journal of gastrointestinal oncology

authors

Inagaki C,Maeda D,Kimura A,Otsuru T,Iwagami Y,Nishida N,Sakai D,Shitotsuki R,Yachida S,Doki Y,Satoh T

doi

10.4251/wjgo.v11.i9.761

subject

Has Abstract

pub_date

2019-09-15 00:00:00

pages

761-767

issue

issn

1948-5204

journal_volume

pub_type

在线工具

Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.